Published in J Am Soc Nephrol on June 01, 1995
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2010) 2.47
Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol (2012) 2.10
Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney Int (2009) 1.95
A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol (2013) 1.72
Association of cardiac troponin T with left ventricular structure and function in CKD. Am J Kidney Dis (2013) 1.67
Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis (2007) 1.38
The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol (2010) 1.21
Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol (2011) 1.17
Cost-effectiveness of frequent in-center hemodialysis. J Am Soc Nephrol (2008) 1.13
Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol (2009) 1.13
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol (2009) 1.06
Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clin J Am Soc Nephrol (2013) 1.01
Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol (2013) 0.98
Chronic kidney disease and cardiovascular complications. Heart Fail Rev (2015) 0.95
NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy. Br J Pharmacol (2006) 0.95
Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol (2013) 0.94
Heart function disturbances in chronic kidney disease - echocardiographic indices. Arch Med Sci (2014) 0.93
The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy. Neth Heart J (2010) 0.93
Abdominal aortic calcification is associated with diastolic dysfunction, mortality, and nonfatal cardiovascular events in maintenance hemodialysis patients. J Korean Med Sci (2012) 0.92
Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients. Semin Dial (2008) 0.92
Longitudinal changes of cardiac structure and function in CKD (CASCADE study). J Am Soc Nephrol (2014) 0.90
Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction. Croat Med J (2009) 0.90
Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients. Pediatr Nephrol (2004) 0.88
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Med (2015) 0.87
Long-term effects of spironolactone in peritoneal dialysis patients. J Am Soc Nephrol (2013) 0.86
Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One (2015) 0.86
Echocardiography-based score to predict outcome after renal transplantation. Heart (2006) 0.85
Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice. Am J Physiol Heart Circ Physiol (2014) 0.84
Predicting risk of mortality in dialysis patients: a retrospective cohort study evaluating the prognostic value of a simple chest X-ray. BMC Nephrol (2013) 0.84
Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin J Am Soc Nephrol (2011) 0.83
Bioimpedance and echocardiography used interchangeably in volume comparison of dialysis patients. Hippokratia (2012) 0.83
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors. Hypertension (2016) 0.83
Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.82
Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia. Biomark Insights (2008) 0.82
The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: rationale and study design of a randomized controlled pilot study. BMC Nephrol (2006) 0.82
Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol (2015) 0.81
Left ventricular dysfunction in the haemodialysis population. NDT Plus (2008) 0.81
Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS Study. Int J Hypertens (2013) 0.80
Overhydration, Cardiac Function and Survival in Hemodialysis Patients. PLoS One (2015) 0.80
The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol (2004) 0.79
Effect of anemia on cardiac disorders in pre-dialysis patients immediately before starting hemodialysis. Clin Exp Nephrol (2010) 0.79
Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents. Clin Exp Nephrol (2012) 0.79
Reducing cardiovascular mortality in chronic kidney disease: something borrowed, something new. J Clin Invest (2013) 0.79
Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping. Kidney Int (2016) 0.78
Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease. Nephrol Dial Transplant (2011) 0.78
Cardiovascular and renal effects of bromocriptine in diabetic patients with stage 4 chronic kidney disease. Biomed Res Int (2013) 0.78
Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients. Heart Vessels (2011) 0.77
Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial. BMC Nephrol (2016) 0.77
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease. Curr Opin Nephrol Hypertens (2014) 0.77
Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis. BMC Nephrol (2010) 0.77
Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients. Heart Vessels (2010) 0.76
Predictive Value of Echocardiographic Abnormalities and the Impact of Diastolic Dysfunction on In-hospital Major Cardiovascular Complications after Living Donor Kidney Transplantation. Int J Med Sci (2016) 0.75
Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD. Clin J Am Soc Nephrol (2016) 0.75
Short daily versus conventional hemodialysis for hypertensive patients: a randomized cross-over study. PLoS One (2014) 0.75
The effects of frequent hemodialysis on left ventricular mass, volumes, and geometry. Clin J Am Soc Nephrol (2013) 0.75
Serum alkaline phosphatase levels and left ventricular diastolic dysfunction in patients with advanced chronic kidney disease. Nephron Extra (2012) 0.75
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study. Oxid Med Cell Longev (2016) 0.75
Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients. J Atheroscler Thromb (2016) 0.75
QT-interval parameters in end-stage renal disease--is cardiovascular autonomic neuropathy unimportant? Clin Auton Res (2004) 0.75
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease. Semin Nephrol (2017) 0.75
Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients. PLoS One (2017) 0.75
Speckle tracking determination of mitral tissue annular displacement: comparison with strain and ejection fraction, and association with outcomes in haemodialysis patients. Int J Cardiovasc Imaging (2016) 0.75
Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 10.70
Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol (1998) 4.67
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int (1995) 3.70
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int (1998) 3.09
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis (1996) 2.75
Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet (2000) 2.53
Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet (2000) 2.45
The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med (1988) 2.36
Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant (1996) 2.21
Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int (1995) 2.06
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int (1996) 1.99
Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol (1996) 1.64
Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64
Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol (2001) 1.58
Contrast nephropathy. J Am Soc Nephrol (2000) 1.54
Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol (2000) 1.52
Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial. Radiology (1992) 1.51
A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31. Am J Hum Genet (1999) 1.49
Audit of the Medical Audit Committee. CMAJ (1986) 1.49
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int (2000) 1.48
Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int (1996) 1.46
Cardiovascular disease and mortality in ESRD. J Nephrol (1999) 1.40
Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer (2007) 1.39
Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med (2000) 1.39
Phagocytosis and related phenomena in polymorphonuclear leukocytes from cow's milk. Can J Comp Med (1969) 1.33
Patients' perceptions of their experiences with ESRD and hemodialysis treatment. Qual Health Res (1998) 1.31
The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis (1996) 1.30
Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int (2000) 1.24
Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med (1999) 1.23
The emotional impact of end-stage renal disease: importance of patients' perception of intrusiveness and control. Int J Psychiatry Med (1984) 1.23
Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am J Hum Genet (2001) 1.23
The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut (2010) 1.23
Role of diagnostic labeling in antibiotic prescription. Can Fam Physician (2001) 1.20
Clinimetrics in nephrology. Nephron (1986) 1.18
A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med (1992) 1.18
Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med (1994) 1.16
Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol (1994) 1.16
Coronary artery bypass graft surgery in Newfoundland and Labrador. CMAJ (1998) 1.15
Canadian Bardet-Biedl syndrome family reduces the critical region of BBS3 (3p) and presents with a variable phenotype. Am J Med Genet (1998) 1.15
Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis (1997) 1.13
Rationale and perspectives on the development of fungicides. Annu Rev Phytopathol (1997) 1.13
Autosomal dominant polycystic kidney disease: new information for genetic counselling. Am J Med Genet (1992) 1.09
Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study. Am J Kidney Dis (1998) 1.07
The role of the kidney in essential hypertension. Br J Hosp Med (1980) 1.07
Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation (2000) 1.07
Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. Genomics (1999) 1.05
Impact of renal transplantation on uremic cardiomyopathy. Transplantation (1995) 1.04
Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch Intern Med (1985) 1.04
A founder effect in the newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM. Am J Hum Genet (1999) 1.03
Basal release of nitric oxide induces an oscillatory motor pattern in canine colon. J Physiol (1997) 1.03
Combined central retinal vein occlusion and cilioretinal artery occlusion in a patient on hormone replacement therapy. Br J Ophthalmol (2000) 1.02
Blood pressure and hormonal changes following alteration in dietary sodium and potassium in mild essential hypertension. Lancet (1981) 1.02
The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation (1985) 1.00
Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther (1997) 0.99
Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol (1998) 0.98
Idiopathic calcium phosphate nephrolithiasis. Nephron (1988) 0.98
Hemodynamic and pulmonary changes following surgical creation of a diaphragmatic hernia in fetal lambs. Surgery (1972) 0.96
Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int (1992) 0.95
Cardiac function and hematocrit level. Am J Kidney Dis (1995) 0.95
Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis (1994) 0.94
Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation. Clin Genet (2011) 0.93
Cardiac disease in diabetic end-stage renal disease. Diabetologia (1997) 0.93
Seismic reflection images of the Moho underlying melt sills at the East Pacific Rise. Nature (2006) 0.93